| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.24B | +15.0% |
| Cost of Revenue | $527.0M | +25.2% |
| Gross Profit | $1.71B | +12.1% |
| R&D Expense | $585.0M | +4.5% |
| SG&A Expense | $524.0M | -5.2% |
| Operating Income | -$197.0M | +27.0% |
| Interest Expense | $36.0M | +0.0% |
| Pre-tax Income | -$107.0M | +30.5% |
| Income Tax | $5.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.08B | -27.5% |
| Accounts Receivable | $104.0M | +8.3% |
| Current Assets | $2.33B | -25.9% |
| Total Assets | $5.83B | -12.4% |
| Current Liabilities | $831.0M | -14.4% |
| Total Liabilities | $981.0M | -53.9% |
| Stockholders' Equity | $4.85B | +7.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $428.0M | +20.9% |
| Capital Expenditures | $143.0M | +5.9% |
| Investing Cash Flow | $395.0M | +1480.0% |
| Financing Cash Flow | -$1.23B | -250.3% |
| Free Cash Flow | $285.0M | +30.1% |
| +25.0% |
| Net Income | -$112.0M | +29.1% |
| EPS (Basic) | -$0.48 | +29.4% |
| EPS (Diluted) | -$0.48 | +29.4% |